Picture

Abel Costa, MD @anetoc

Hematologist. Tweets are my own. São Paulo, Brasil Joined July 2010
  • Tweets
    461
  • Followers
    697
  • Following
    662
  • Likes
    1K
Abel Costa, MD retweeted
tobyeyre82 Profile Picture

Toby Eyre @tobyeyre82

a month ago

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up† - Annals of Oncology annalsofoncology.org/article/S0923-…

Abel Costa, MD retweeted
EMN_EuMMnet Profile Picture

EMN @EMN_EuMMnet

2 months ago

📢We are proud to announce that the EHA-EMN guidelines for the diagnosis, treatment and follow-up of #MultipleMyeloma are now available online! Huge thanks to Evangelos Terpos for coordinating such outstanding work! 👉nature.com/articles/s4157… @thanosdimop @EHA_Hematology

Abel Costa, MD retweeted
graham74GC Profile Picture

Graham Collins @graham74GC

3 months ago

Nivo-AVD vs BV-AVD in older pts (60+) with #Hodgkin. S1826 data. 99 eligible pts. 2y PFS • 89% Nivo-AVD • 64% BV-AVD 55% discontinued BV, 14% Nivo NRM 16% BV-AVD, 6% Nivo-AVD Transformational. If only we had access! #lymsm ascopubs.org/doi/10.1200/JC…

Abel Costa, MD retweeted
laura_korin Profile Picture

Laura Korin @laura_korin

3 months ago

@tobyeyre82 on treatment options in R/R MCL exposed in 1L to BtKi. Time limites exposure to BTKi allows for reexposure at 1st relapse (+/- venetoclax) #18icml #icml2025

Abel Costa, MD retweeted
graham74GC Profile Picture

Graham Collins @graham74GC

3 months ago

Lewis et al - MRD analysis in ENRICH: IR vs R-chemo in 1L MCL • flow cytometry based • MRD- most rapid with BR • with RCHOP, even MRD- pts do poorly • with IR, no assocn with MRD & outcome #18ICML #ICML25 #lymsm

Abel Costa, MD retweeted
graham74GC Profile Picture

Graham Collins @graham74GC

3 months ago

Patel: JNJ4496 (anti CD19/20 tandem CAR) RR DLBCL, 41BB costim • global Ph 1B • med age 72y • at RP2D, ORR 100%, CRR 80% • no G3+ CRS, 8% ICANs Very impressive results #18ICML #ICML25 #lymsm

Abel Costa, MD retweeted
graham74GC Profile Picture

Graham Collins @graham74GC

3 months ago

Sancho et al - POLARGO. • RGemOx vs Pola-RGemOx R/R DLBCL • 2L+ DLBCL (no ASCT eligible if 2L) • OS primary EP: signif adv 12.5mo vs 19.5mo • PFS & CMR rate better • tox modest - ⬆️ infn & PN • no effect of cell of origin Interesting but ? value if 1L PolaRCHP #18ICML

Abel Costa, MD retweeted
laura_korin Profile Picture

Laura Korin @laura_korin

3 months ago

How we translate a genomic classification into treatment! #ICML2025 #18ICML

Abel Costa, MD retweeted
Abdallah81MD Profile Picture

Al-Ola A Abdallah MD (USMIRC) @Abdallah81MD

8 months ago

🚨🚨a 🧵 of AURIGA Study 1/The study aimed to determine if adding daratumumab to standard lenalidomide maintenance would improve outcomes in MRD-positive patients with at least VGPR post-ASCT Phase 3, Randomized, Open-Label Trial: A multicenter study randomizing patients 1:1 to…

Abel Costa, MD retweeted
VincentRK Profile Picture

Vincent Rajkumar @VincentRK

9 months ago

Post #ASH24. Active myeloma drugs in one table with mechanism of action. Revised slide. Bookmark! Black font — Approved drugs Blue font — Investigational #ASH24VR

Abel Costa, MD retweeted
VincentRK Profile Picture

Vincent Rajkumar @VincentRK

9 months ago

Just out: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma #ASH24 @thanosdimop @NEJM Daratumumab significantly prolongs time to active myeloma and overall survival. Proud to be a lead investigator of this trial nejm.org/doi/full/10.10… Slides in thread

Abel Costa, MD retweeted
VincentRK Profile Picture

Vincent Rajkumar @VincentRK

9 months ago

My Annual Updated Myeloma Treatment Algorithms thread. Bookmark! #ASH24 #ASH24VR 1. Newly diagnosed transplant ineligible. Quadruplet unless frail. Maintenance varies by risk stratification.

Abel Costa, MD retweeted
Myeloma_Doc Profile Picture

Robert Z. Orlowski @Myeloma_Doc

10 months ago

#Myeloma Paper of the Day: Brazilian study of real-life experience of myeloma (MMyBRAve) finds improvement in outcomes (median OS in transplantation-ineligible and eligible patients of 49 & 93 months), but remaining diagnostic and therapeutic gaps: pubmed.ncbi.nlm.nih.gov/39488485/. #mmsm

Abel Costa, MD retweeted
tobyeyre82 Profile Picture

Toby Eyre @tobyeyre82

10 months ago

Salles et al 5 yr results of POLARIX 1L RCT PolaRCHP vs RCHOP in IPI 2-5 DLBCL 5-year PFS estimates 64.2% vs 59.1% HR 0.78; 95% CI: 0.623-0.980 5-year OS 82.2% vs 79.6% not significant #ASH2024 #lymsm

Abel Costa, MD retweeted
MM_Hub Profile Picture

Multiple Myeloma Hub @MM_Hub

11 months ago

CONGRESS | #IMS2024 | PRESENTATION Abel Costa @anetoc shares findings from a trial of sonrotoclax + dexamethasone in patients with RRMM harboring t(11;14) mutations (N=32). The ORR was 75% among 24 efficacy-evaluable patients, with a ≥ VGPR of 50%. The combination was well…

Abel Costa, MD retweeted
UsuarezMD Profile Picture

Uriel Suárez @UsuarezMD

a year ago

R/R T-ALL. Therapeutic approach. - How I treat, blood journal 2023. - ESMO guidelines 2024. - ELNetwork guidelines 2024. - NCCN guidelines 2024. What is the best scheme before the alloSCT (antiCD38, Bortezomib, VEN…) ?

Abel Costa, MD retweeted
TomBmt133 Profile Picture

Tom Martin @TomBmt133

a year ago

Great presentation by Suzanne Lentzsch on Linvoeltamab on RRMM - ORR 71% ,CRS 46%, and a high PFS (70%) at 12mos - need to see if this holds up - ? Best in class or selection bias- too early to tell

Abel Costa, MD retweeted
bhemato Profile Picture

Binod Dhakal @bhemato

a year ago

Next generation CAR with novel binding domain! Deep and durable response in high risk patients! Look forward to getting this to our patients! ⁦@MCWCancerCenter⁩ ⁦@EHA_Hematology⁩ #eha2024

Abel Costa, MD retweeted
JoshuaRichterMD Profile Picture

Joshua Richter, MD, FACP @JoshuaRichterMD

a year ago

Guideline paradigms in EMD @JHillengass at #IMWG2024. @Myeloma_Society #mmsm

anetoc Profile Picture

Abel Costa, MD @anetoc

a year ago

Check out our poster at #EHA2024 with safety and efficacy data from the Ph 1/2 study with Golcadomide +/- Ritux for R/R FL @GuiperiniMD

Trends for United States

Bears
146 B posts
Caleb
84,1 B posts
JJ McCarthy
43,9 B posts
#Skol
16,8 B posts
Ben Johnson
21,2 B posts
MMTFinance
13,3 B posts
Tanner Scott
2.370 posts
DJ Moore
5.731 posts
#WWERaw
87,2 B posts
#MINvsCHI
4.752 posts
Justin Jefferson
10,8 B posts
Kevin O'Connell
2.776 posts
Cairo
6.081 posts
Bagent
1.633 posts
Through Giverep
2.054 posts
With Giverep
13 B posts
Glasnow
2.568 posts
Swift
61,7 B posts
Cyrene
75 B posts
Vikes
3.836 posts

You might like

MD PhD - Hematologist at ICESP/University of São Paulo, focus on Acute Leukemias
Wellington Fernandes
@wellingtonhemat
1K Followers
Hematologist - specialized in blood malignancies and hematopoietic stem cell transplant, Head of hematology department at A.C.Camargo Cancer Center
Jayr Schmidt Filho
@jayrsf_
1K Followers
Father. Husband. Son. Hematologist. Data Scientist. Comics. RPG. Rocker. Nostr: npub1ff28pnm4hu5p6cp3nxga2xyh52rx2nfnuqqqds0ctdpm9c8l7wwsk2w56u
Fabio Pires
@fabiopss
1K Followers
Hematologist #mentoring #education #IFI #aml #myeloproliferative 🌈
Mariana Guarana
@mariana_guarana
822 Followers
Hematologist at São Paulo State University- UNESP - Brazil #myeloma #pnh #ArtOfMedicine. Tweets are my own.
Lucas Cantadori
@lucascantadori
722 Followers
Brazilian Hematologist (Rio de Janeiro).Bone Marrow Transplant Specialist by CEMO/INCA. ESO's Certificate of Competence in Lymphoma CCL6 #lymsm
Isabela
@isaisabelagap
943 Followers
Hematologist in Sao Paulo, Brazil. Focus on Lymphomas and CLL Host: Fase 3 Podcast
Guilherme Perini, MD
@GuiperiniMD
3K Followers
Referência em câncer do sangue | Pioneiro CAR T-Cell na América Latina | Prof UNIFESP | Líder Oncoclínicas |📍São Paulo-SP | Instagram: dr.renato.cunha |
Renato Cunha, M.D.-Ph...
@DrRenatoCunha
1K Followers
Hematologist at Bone Marrow Transplantation Unit of Ribeirão Preto FMRP-USP, Brazil
Thalita Costa
@tcm_costa
204 Followers
🩸 The Fellow on Call: The Heme/Onc Podcast! | New episodes on Wednesdays | 📸 Insta: @TheFellowOnCall || RT ≠ Endorsement
The Fellow On Call
@TheFellowOnCall
4K Followers